CAS 38975-44-9

5-(3,7-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)pentanoic acid

Description:

5-(3,7-Dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)pentanoic acid, with the CAS number 38975-44-9, is a chemical compound that belongs to the class of purine derivatives. This substance features a purine ring structure, which is characterized by its bicyclic arrangement of carbon and nitrogen atoms. The presence of two carbonyl (dioxo) groups contributes to its reactivity and potential biological activity. The pentanoic acid moiety indicates that it has a five-carbon aliphatic chain, which may influence its solubility and interaction with biological systems. The dimethyl substitutions on the purine ring suggest that it may exhibit unique steric and electronic properties, potentially affecting its pharmacological profile. This compound may be of interest in medicinal chemistry, particularly in the development of pharmaceuticals targeting purine metabolism or related pathways. As with many chemical substances, its specific properties, such as solubility, melting point, and biological activity, would require empirical investigation for detailed characterization.

Formula: C₁₂H₁₆N₄O₄

InChI: InChI=1/C12H16N4O4/c1-14-7-13-10-9(14)11(19)16(12(20)15(10)2)6-4-3-5-8(17)18/h7H,3-6H2,1-2H3,(H,17,18)

SMILES: Cn1cnc2c1c(=O)n(CCCCC(=O)O)c(=O)n2C

1-(4''-Carboxybutyl)-3,7-dimethylxanthine

CAS: 38975-44-9

Ref: 7W-GW9713

Pentoxifylline Impurity 11

CAS: 38975-44-9

Formula: C₁₂H₁₆N₄O₄

Molecular weight: 280.28

Ref: 4Z-P-0525

1-(4-Carboxybutyl)-3,7-dimethylxanthine

Controlled Product

CAS: 38975-44-9

Formula: C₁₂H₁₆N₄O₄

Color and Shape: White To Off-White

Molecular weight: 280.28

Ref: TR-C177680

1-(4-Carboxybutyl)-3,7-dimethylxanthine

Controlled Product

CAS: 38975-44-9

1-(4-Carboxybutyl)-3,7-dimethylxanthine (1CBMX) is a drug that has been shown to interact with cancer cells and inhibit their growth. It also has the ability to reverse multidrug resistance in cancer cells by inhibiting human multidrug resistance proteins. 1CBMX is able to cause significant effects on cancer cells in vitro, but it does not show any significant effects on platelets or human endothelial cells. 1CBMX is being studied as a potential treatment for endothelioma and fibrosarcoma cells. It inhibits the ATPase activity of these tumor cell lines in a dose-dependent manner, leading to an inhibition of cell proliferation and increased cell death.

Formula: C₁₂H₁₆N₄O₄

Purity: Min. 95%

Molecular weight: 280.28 g/mol

Ref: 3D-NBA97544